Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-8500
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shuang Zhao, MD is a radiation oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Michigan.
Education & Training
University of MichiganResidency, Radiation Oncology, 2016 - 2020
University of Michigan Medical SchoolClass of 2015
Certifications & Licensure
WI State Medical License 2020 - 2025
MI State Medical License 2015 - 2019
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer.Marina N Sharifi, Eric Feng, Nicholas R Rydzewski, Amy K Taylor, Jamie M Sperger
Molecular Oncology. 2025-02-22 - High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.Marina N Sharifi, Jamie M Sperger, Amy K Taylor, Katharine E Tippins, Shannon R Reese
Cancer Discovery. 2025-02-06 - Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library.Gihan S Gunaratne, Joseph P Gallant, Kendahl L Ott, Payson L Broome, Sasha Celada
Biorxiv. 2025-01-13
Press Mentions
PORTOS Validation in Phase 3 Trials: Gene Signature Predictor of Dose-Response to Prostate RadiationFebruary 24th, 2025- New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer ResearchFebruary 14th, 2025
- Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU SymposiumFebruary 11th, 2025
- Join now to see all
Grant Support
- Cell-free DNA fragmentomics as prognostic and treatment resistance biomarkers in metastatic castration-resistant prostate cancerUNIVERSITY OF WISCONSIN-MADISON2025–2030
- DYNAMIC MOLECULAR EVOLUTION OF TREATMENT RESISTANT CANCERUNIVERSITY OF WISCONSIN-MADISON2021–2026
- DYNAMIC MOLECULAR EVOLUTION OF TREATMENT RESISTANT CANCERUNIVERSITY OF WISCONSIN-MADISON2021–2026
- DYNAMIC MOLECULAR EVOLUTION OF TREATMENT RESISTANT CANCERUNIVERSITY OF WISCONSIN-MADISON2021–2026
